rs10862841 - RPL6P25 - SLC6A15
Magnitude 2.2 · 2 studies on file
Reported associations
-
Genome-wide meta-analysis of insomnia prioritizes genes associated with metabolic and psychiatric pathways. - Nature genetics (2022) · Watanabe K, Jansen PR, Savage JE, Nandakumar P, Wang X, Hinds DA, Gelernter J, Levey DF, Polimanti R, Stein MB, Van Someren EJW, Smit AB, Posthuma D · PubMed 35835914
Insomnia is a heritable, highly prevalent sleep disorder for which no sufficient treatment currently exists. Previous genome-wide association studies with up to 1.3 million subjects identified over 200 associated loci. This extreme polygenicity suggested that many more loci remain to be discovered. The current study almost doubled the sample size to 593,724 cases and 1,771,286 controls, thereby increasing statistical power, and identified 554 risk loci (including 364 novel loci). To capitalize on this large number of loci, we propose a novel strategy to prioritize genes using external biological resources and functional interactions between genes across risk loci. Of all 3,898 genes naively implicated from the risk loci, we prioritize 289 and find brain-tissue expression spec
-
Genetic diversity fuels gene discovery for tobacco and alcohol use - Unknown journal (n.d.) · Unknown authors · PubMed 36477530
ABSTRACT: Tobacco and alcohol use are heritable behaviours associated with 15% and 5.3% of worldwide deaths, respectively, due largely to broad increased risk for disease and injury. These substances are used across the globe, yet genome-wide association studies have focused largely on individuals of European ancestries. Here we leveraged global genetic diversity across 3.4 million individuals from four major clines of global ancestry (approximately 21% non-European) to power the discovery and fine-mapping of genomic loci associated with tobacco and alcohol use, to inform function of these loci via ancestry-aware transcriptome-wide association studies, and to evaluate the genetic architecture and predictive power of polygenic risk within and across populations. We found that increases in s
Auto-generated from study metadata. AI-synthesised commentary is added when this entry is regenerated through content-service's LLM mode.
Lifestyle context
Concrete actions anchored to the cited research. We do not prescribe, we describe.
Lifestyle
-
Sleep hygiene practices for insomnia risk Moderate
rs10862841 A allele associated with increased insomnia risk; optimized sleep habits may mitigate susceptibility
Maintain consistent sleep schedule, cool dark bedroom, no screens 1 hour before sleep, limit caffeine after 2pm
-
Tobacco and nicotine products Moderate
rs10862841 A allele associated with increased smoking initiation risk across 3.4 million individuals in GWAS
Avoid all tobacco products including cigarettes, vaping, chewing tobacco, and nicotine replacement
Screening
-
Insomnia screening and risk monitoring Moderate
rs10862841 A allele robustly associated with insomnia susceptibility across 2.3 million individuals in GWAS
Assess sleep quality regularly; consult sleep specialist if insomnia symptoms develop